Progressive Supranuclear Palsy Clinical Trials

12 recruiting

Frequently Asked Questions

Common questions about Progressive Supranuclear Palsy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 118 of 18 trials

Recruiting

Synaptic Loss in Multiple System Atrophy

Multiple System AtrophyProgressive Supranuclear Palsy (PSP)
University of Exeter36 enrolled1 locationNCT05121012
Recruiting

Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Biomarkers

Healthy ControlMultiple System AtrophyProgressive Supranuclear Palsy (PSP)+1 more
Beijing Tiantan Hospital720 enrolled1 locationNCT07392411
Recruiting

Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging

Multiple System AtrophyParkinson DiseaseProgressive Supranuclear Palsy
University of Texas Southwestern Medical Center90 enrolled1 locationNCT03872102
Recruiting

UPenn Observational Research Repository on Neurodegenerative Disease

Corticobasal Syndrome(CBS)Progressive Supranuclear Palsy (PSP)Primary Progressive Aphasia(PPA)+6 more
University of Pennsylvania1,000 enrolled1 locationNCT04715399
Recruiting

The CurePSP Genetics Program

PSPPSP - Progressive Supranuclear PalsyCorticobasal Syndrome+4 more
Massachusetts General Hospital1,000 enrolled1 locationNCT06647641
Recruiting
Not Applicable

tDCS as Treatment for Motor Function

Parkinson DiseaseProgressive Supranuclear PalsyCortical Basal Ganglionic Degeneration
Baycrest20 enrolled1 locationNCT07291687
Recruiting

Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling

DementiaAlzheimer DiseaseParkinson Disease+7 more
University Health Network, Toronto500 enrolled4 locationsNCT06529744
Recruiting
Not Applicable

Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology

Myasthenia GravisHuntington DiseaseNeuromuscular Diseases+9 more
Centre Hospitalier Universitaire de Liege300 enrolled1 locationNCT07136844
Recruiting

Gait Analysis in Neurological Disease

Multiple System AtrophyHuntington DiseaseCorticobasal Degeneration+5 more
Beth Israel Deaconess Medical Center120 enrolled1 locationNCT02994719
Recruiting
Not Applicable

Neurologic Stem Cell Treatment Study

Cognitive ImpairmentDementiaTraumatic Brain Injury+23 more
MD Stem Cells500 enrolled3 locationsNCT02795052
Recruiting
Not Applicable

The Swedish BioFINDER 2 Study

DementiaMultiple System AtrophyAlzheimer Disease+9 more
Skane University Hospital1,505 enrolled2 locationsNCT03174938
Recruiting

AI-Enhanced Optimization of Acute Levodopa Challenge Test

Corticobasal Degeneration (CBD)Progressive Supranuclear Palsy (PSP)Parkinson Disease (PD)+4 more
Beijing Tiantan Hospital2,000 enrolled1 locationNCT06949865
Recruiting

Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases

Multiple System AtrophyParkinson DiseaseMotor Neuron Disease+2 more
Kliniken Beelitz GmbH350 enrolled16 locationsNCT04706234
Recruiting

NYSCF Scientific Discovery Biobank

Ovarian CancerCervical CancerDiabetes Mellitus+26 more
New York Stem Cell Foundation Research Institute10,000 enrolled1 locationNCT06203106
Recruiting
Not Applicable

The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders

Multiple System AtrophyCorticobasal DegenerationDystonia+5 more
Queen Mary University of London70 enrolled1 locationNCT06174948
Recruiting

Biomarkers in Parkinsonian Syndromes

Multiple System AtrophyParkinson DiseaseProgressive Supranuclear Palsy+2 more
Non-profit organization for scientific research in Parkinson's disease and related disorders200 enrolled1 locationNCT06501469
Recruiting

NMR Based Metabolomic Study of Serum Biomarkers in Patients With Parkinson's Disease and Atypical Parkinsonian Syndrome

Multiple System AtrophyProgressive Supranuclear PalsyParkinson's Disease
Fujian Medical University Union Hospital180 enrolled1 locationNCT06490926
Recruiting

Modifiable Variables in Parkinsonism (MVP)

Corticobasal DegenerationDementia With Lewy BodiesProgressive Supranuclear Palsy+6 more
Bastyr University2,000 enrolled1 locationNCT02194816